The client walks in with 60% of her household net worth in a single ticker. She got there honestly — twenty-three years at the same employer, a steady RSU vest cadence, an ESPP plan that compounded silently, an ISO exercise in 2017 that turned out spectacularly, and a complete inability to bring herself to sell because she "knows the company." She is not your problem to fix in a single meeting; she is your problem to memorialize in a Reg BI-defensible decision memo that surfaces six named alternatives, models the after-tax outcome of each, and documents the client-specific reason for the recommendation you ultimately make. This lesson installs the AI workflow that turns the concentrated-stock conversation from an emotionally-charged, fact-pattern-light advisory hand-wave into a numbered, auditable, signoff-ready artifact.

The Baseline and the Six Named Alternatives

The first step in any concentrated-stock engagement is the baseline: how concentrated, how appreciated, in what tax bracket, in what state, with what other liquidity sources, with what dependent obligations, and against what IPS policy range. The AI workflow pulls these inputs from Wealthbox or Salesforce FSC (the household profile), Orion Eclipse or the custodian feed (the position-level cost basis), Holistiplan's extraction of the prior-year 1040 (the marginal-rate context), and the IPS itself (the policy concentration limit). The output is a one-page baseline: ticker, share count, current value, aggregated cost basis, unrealized gain, household concentration percentage, IPS-policy concentration limit, federal marginal rate, state of residence, NIIT exposure, and the client's stated emotional disposition toward the position.

From the baseline, the AI produces the six standard alternatives — the same six the Reg BI Care Obligation under §240.15l-1(a)(2)(ii) requires the file to consider and document: (1) hold, (2) sell with tax-loss-harvest offset from elsewhere in the household, (3) exchange fund, (4) charitable trust (CRT or CLAT), (5) direct indexing with completion-portfolio tax-loss harvesting, and (6) 10b5-1 staggered sale. The advisor's job is not to recommend one of the six in the first meeting; the advisor's job is to walk the client through the after-tax outcome of each so the client can hold the trade-off in her own head.

Why Six Alternatives, Not Three

The 2025-2026 FINRA AWC pattern on inadequate Reg BI documentation hits firms that document two or three alternatives and skip the rest. The decision memo that says "we considered hold vs. sell" and stops there fails Care Obligation review the moment an examiner asks why the exchange fund or the CRT wasn't surfaced. The six-alternative framework is the practical floor; in a high-net-worth household the practical ceiling adds a seventh (private-foundation funding) and an eighth (in-kind charitable gifting to a Donor-Advised Fund), both of which the memo flags as in-scope for the next planning year.

Alternative 1 — Hold, and the Cost of Doing Nothing

The hold alternative is the baseline against which the other five are measured. The AI's job is to make the hold alternative concrete: project the position's expected value, volatility, and idiosyncratic-risk haircut over a five- and ten-year horizon; quantify the household's resulting probability of meeting its stated retirement goal under a Monte Carlo run inside RightCapital, eMoney, or MoneyGuidePro; and surface the position's contribution to portfolio-level concentration risk against the IPS allocation policy. The hold memo includes the IPS-breach quantification — the client is signing a hold recommendation that explicitly acknowledges the IPS policy range is being violated by 35 percentage points, and the advisor is signing a Reg BI memo that documents why the violation is consistent with the client's stated objectives and risk tolerance.

The hold alternative is rarely the recommended path for a 60%-concentration household, but it is frequently the actual path because the client refuses to sell. The memo's role in that scenario is to insulate the advisor from the next decade of "you should have made me sell" complaints by documenting that the client was presented with the full set of alternatives, the financial cost of each was quantified, and the client made the decision in writing. The Reg BI Disclosure Obligation under §240.15l-1(a)(2)(i) gets satisfied; the Care Obligation gets satisfied; the Conflict Obligation gets satisfied (the advisor's AUM fee on the position is disclosed); the Compliance Obligation gets satisfied (the firm has written supervisory procedures for concentrated-position recommendations).

Alternative 2 — Sell with Tax-Loss-Harvest Offset

The straight-sell alternative is mechanically simple and tax-painfully expensive. The AI workflow runs the math: realized long-term capital gain on the full position liquidation, federal LTCG rate (typically 20% for the household profile, with 23.8% inclusive of the §1411 net investment income tax), state tax (which ranges from 0% in Florida or Texas to 13.3% in California for the top bracket), and total cash drag. For the 60%-concentration household with a $2.4M position and a $400K aggregated basis, the straight sale generates $2M of LTCG and roughly $476,000 of federal tax (at 23.8% inclusive) plus state tax — for a California resident, an additional $266,000 — for a total tax cost of $742,000 against $2,400,000 of proceeds, or a 31% effective drag.

The tax-loss-harvest overlay reduces the drag. The AI scans the rest of the household's taxable accounts for unrealized losses (any direct-indexing SMA, individual equity positions with embedded losses, ETFs that traded down recently) and quantifies the available offset. For a household running a Parametric, Aperio, Eaton Vance, or Vanguard Personalized Indexing direct-indexed SMA against the S&P 500, the typical year produces 1-2% of harvested-loss proceeds usable against the concentrated position's gains; for the $2.4M position, that translates to $24,000-$48,000 of LTCG offset, or roughly $6,000-$11,000 in federal-tax savings. The number is real but it does not solve the concentration problem on its own; the AI's job is to size it accurately so the client can read the trade-off.

Alternative 3 — Exchange Fund

The exchange fund — also known as a swap fund or §721 fund — is the tax-deferral vehicle most-pitched and least-understood in the concentrated-stock playbook. The client contributes appreciated stock to a partnership in exchange for a pro-rata interest in a diversified pool of similarly contributed positions. The contribution is generally tax-free under §721 (no gain recognized at contribution). The partnership is required to hold at least 20% qualifying investments (non-marketable securities, typically real estate) to qualify under §721(b). The partner must hold the partnership interest for at least seven years; on the back end, the partner can redeem her interest for a pro-rata slice of the diversified pool, taking the basis of her original contribution into the new positions.

The AI workflow on this alternative pulls the current exchange-fund providers (Eaton Vance, Goldman Sachs, Morgan Stanley, AB Bernstein, Cache, BNY Mellon, USAA — the 2026 landscape) and models the all-in cost: the fund's annual management fee (typically 0.75-1.25%), the seven-year lock-up illiquidity discount on the client's net worth, the diversification benefit (the partner gets the diversified pool's risk-return profile, not the original ticker's), the eventual basis carryover (the original low basis follows the partner into the diversified pool), and the qualification-risk cost (if the fund fails to maintain the 20% qualifying-investment threshold, the entire structure collapses retroactively). For a $2.4M position holder, the exchange-fund alternative is meaningfully attractive when concentration is the primary problem and the client values diversification over immediate liquidity; it is unattractive when the client needs near-term cash, lives in a state that doesn't recognize federal partnership treatment cleanly, or already holds adequately diversified non-concentrated assets.

Alternative 4 — Charitable Trust (CRT or CLAT)

The charitable remainder trust under §664 and the charitable lead annuity trust under §170(f)(2)(B) and §2522(c)(2)(B) are the two charitable vehicles most-frequently considered for the concentrated-stock disposition. The CRT mechanics: the client contributes the appreciated stock to an irrevocable trust, the trust sells the stock tax-free (charitable trusts are exempt from capital-gains tax), the trust pays the client (or named beneficiary) a fixed annuity or unitrust percentage for a term of years or for life, and the remainder passes to a named charity at termination. The client gets a charitable deduction equal to the present value of the remainder interest (computed under the §7520 rate), the gain on the contributed stock is deferred (and partially eliminated, depending on the unitrust payout sequencing under the §664(b) four-tier rules), and the charity ultimately benefits.

The CLAT mechanics are the inverse: the trust pays a charity for a term of years, with the remainder reverting to the grantor or her named beneficiaries. The CLAT is favored in low-§7520-rate environments (which make the charitable lead actuarially less expensive) and in households with significant charitable intent plus a desire to transfer wealth to the next generation tax-efficiently. The AI workflow runs the CRT vs CLAT comparison under three §7520-rate scenarios (the current rate plus +/-1%), three payout-cadence scenarios, and three remainder-charity profiles (the client's existing DAF, a private foundation, or a public charity). The output is a one-page comparative exhibit with the after-tax-and-charitable-impact present value of each, cross-referenced to L3 Ch5 L3 on the advanced vehicle decision tree where the SLAT, ILIT, and private-foundation alternatives sit.

The Pre-Sale Funding Window

The CRT or CLAT must be funded before the sale event is binding (before a signed term sheet, before a definitive merger agreement, before the trade is queued). The "assignment of income" doctrine collapses any post-binding transfer into a constructive sale by the grantor, and the entire tax benefit evaporates. The AI's job is to flag the timing requirement up front — the moment the client says "I think I'm going to sell next year" is the moment the CRT/CLAT modeling needs to start, not the moment after she has signed the trade authorization. For the IPO-window or tender-offer-window client (cross-referenced to L3 Ch6 L4 on business sale planning), the pre-sale funding decision is the single most consequential planning call of the year.

Alternative 5 — Direct Indexing with Tax-Loss Harvesting

The direct-indexing alternative is the slow-and-steady path: the household funds a separately-managed account (Parametric, Aperio, Eaton Vance, Vanguard Personalized Indexing, the 2026 Schwab Personalized Indexing service, or Fidelity Managed FidFolios) that replicates an index (S&P 500, Russell 1000, MSCI ACWI) via individual stocks, the SMA harvests losses tax-aggressively throughout the year (typically generating 1-2% annual harvested losses in a normal market and 3-5% in a drawdown year), and the harvested losses offset the gains realized by gradually liquidating the concentrated position over a five- to ten-year horizon. The strategy works best for households with a long horizon, no urgent liquidity need, and a willingness to underweight the concentrated sector temporarily in the SMA to manage tracking error.

The AI workflow runs a five-year projection: the SMA's expected harvested-loss generation, the year-by-year tranche-sale plan for the concentrated position, the resulting net federal-and-state tax cost, and the tracking error against the underlying index. For the $2.4M position with $2M of embedded gain, a five-year direct-indexing-overlay plan typically reduces the total tax cost by $80,000-$150,000 relative to the straight sale — meaningful but not transformative. The strategy compounds attractively over a ten-year horizon, particularly if combined with charitable-gifting of the lowest-basis lots (Alternative 4) and a 10b5-1 schedule for the executive who is still subject to corporate blackouts (Alternative 6).

Alternative 6 — 10b5-1 Staggered Sale

For the executive client who is still an officer, director, or 10% holder of the employer-stock issuer, the only lawful path to a scheduled sell-down outside the open trading window is a Rule 10b5-1(c) plan. The mechanics, the 120-day cooling-off, the MNPI-free certification, the single-trade plan limit, and the Form 4 disclosure are developed in detail in L3 Ch6 L1 on ISO/NQSO/RSU/ESPP exercise modeling. For the concentrated-stock memo, the 10b5-1 alternative is the time-distributed sale strategy: the AI lays out a tranche-by-tranche, calendar-by-calendar sell schedule that spreads the gain recognition across two, three, or five tax years; cross-references the IPS allocation glide path; integrates with any charitable-gifting tranches; and produces the blueprint the client and her broker (or the bank trustee on the plan) execute.

The 10b5-1 alternative is frequently combined with one of the other five — a 10b5-1 schedule running underneath an exchange-fund contribution, or a 10b5-1 schedule funding a CRT contribution year over year, or a 10b5-1 schedule paired with direct-indexing overlay. The AI's job is to surface the combinations and rank them by after-tax outcome.

The Decision Memo, the Reg BI File, and the CCO Signoff

The deliverable is one document: a six-to-twelve-page concentrated-stock decision memo that includes the baseline, the six alternatives, the after-tax projection for each, the IPS-policy-context analysis, the household-specific reason for the recommendation, the alternatives explicitly rejected and why, the fee-impact disclosure (the AUM-fee implication of selling vs. holding, which is a Reg BI Conflict Obligation point — the advisor earns less if the client liquidates and reinvests in a low-fee index, more if the household stays concentrated under AUM), the Marketing Rule disclosure if any AI-capability claim is referenced, and the human reviewer signoff.

The CCO or designated supervisory principal reviews under FINRA Rule 2210 (the client-facing version) and FINRA Rule 3110 (the supervisory layer). The Smarsh or Global Relay archive captures the memo, the prompts, the AI outputs, the human edits, and the signoff trail under FINRA Rule 4511 and SEC Rule 204-2. The 2025-2026 enforcement reality is that the concentrated-position recommendation is one of the most-scrutinized Reg BI fact patterns in the FINRA exam queue; the file's completeness is the difference between an exam item closed without finding and an AWC with a six-figure fine. The integrated decision memo, cross-referenced to L3 Ch6 L1 (equity-comp), L3 Ch5 L3 (advanced vehicles), L3 Ch8 L1 (charitable strategy), and L2 Ch5 L3 (IPS-to-trade reconciliation), is the deliverable.

Key Takeaways

• The six-alternative framework is the Reg BI Care Obligation floor. Hold, sell with TLH offset, exchange fund, charitable trust (CRT/CLAT), direct indexing with TLH overlay, and 10b5-1 staggered sale. Documenting fewer is the FINRA AWC pattern from 2025-2026.
• The baseline is the AI's first deliverable. Pull from Wealthbox/Salesforce, Orion, Holistiplan, and the IPS. Quantify concentration, marginal rate, NIIT, state tax, and IPS-policy breach in one page.
• Hold is the highest-Reg-BI-risk recommendation because it explicitly violates the IPS policy range and exposes the advisor to "you should have made me sell" complaints. The memo documents the client's informed choice in writing.
• Exchange funds defer under §721, lock for 7+ years, carry over basis, and require the partnership to hold at least 20% qualifying investments under §721(b). The AI prices the all-in cost — management fee, illiquidity, basis carryover, qualification risk.
• CRT/CLAT must be funded BEFORE the sale is binding. The assignment-of-income doctrine collapses any post-binding transfer. The AI surfaces the timing requirement the moment the client mentions a sale.
• Direct indexing reduces total tax cost by $80,000-$150,000 over five years on a $2.4M position with $2M of embedded gain — meaningful but not transformative on its own. Compounds attractively in combination with charitable gifting and 10b5-1.
• The decision memo is one document. Six-to-twelve pages, the six alternatives, the after-tax projections, the IPS context, the recommendation, the rejected alternatives, the fee-impact disclosure, the Marketing Rule disclosure, the CCO signoff. Archived under FINRA Rule 4511 and SEC Rule 204-2.